Showing results (81-90 of 102) with videos related to

Sort By:
Pageof 11
F1000Research|February 3, 2016
Chemotherapy for Late-Stage Cancer Patients: Meta-Analysis of Complete Response RatesMartin L Ashdown, Andrew P Robinson, Steven L Yatomi-Clarke, et al.
Applied and Environmental Microbiology|August 1, 1996
Characterization of the chemical and antimicrobial properties of piscicolin 126, a bacteriocin produced by Carnobacterium piscicola JG126R W Jack, J Wan, J Gordon, et al.
Annals of Surgical Oncology|August 12, 2017
Safety and Efficacy of Isolated Limb Infusion Chemotherapy for Advanced Locoregional Melanoma in Elderly Patients: An Australian Multicenter StudyHidde M Kroon, Brendon J Coventry, Mitchell H Giles, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2002
Adjuvant immunotherapy of patients with high-risk melanoma using vaccinia viral lysates of melanoma: results of a randomized trialPeter Hersey, Alan S Coates, William H McCarthy, et al.
Molecular Pharmaceutics|October 29, 2013
Diamide linked γ-cyclodextrin dimers as molecular-scale delivery systems for the medicinal pigment curcumin to prostate cancer cellsTakaaki Harada, Lauren Giorgio, Tiffany J Harris, et al.
Annals of Surgical Oncology|October 29, 2014
Phase 2 Study of Intralesional PV-10 in Refractory Metastatic MelanomaJohn F Thompson, Sanjiv S Agarwala, B Mark Smithers, et al.
The Medical Journal of Australia|March 8, 2005
Achieving equal standards in medical student education: is a national exit examination the answer?Bogda Koczwara, Martin H N Tattersall, Michael B Barton, et al.
The Lancet. Oncology|May 12, 2012
Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trialBryan H Burmeister, Michael A Henderson, Jill Ainslie, et al.
The Lancet. Oncology|July 25, 2015
Adjuvant lymph-node field radiotherapy versus observation only in patients with melanoma at high risk of further lymph-node field relapse after lymphadenectomy (ANZMTG 01.02/TROG 02.01): 6-year follow-up of a phase 3, randomised controlled trialMichael A Henderson, Bryan H Burmeister, Jill Ainslie, et al.
Australian Journal of General Practice|June 21, 2019
Improving diagnostic accuracy for suspicious melanocytic skin lesions: New Australian melanoma clinical practice guidelines stress the importance of clinician/pathologist communicationRichard Scolyer, H Peter Soyer, John W Kelly, et al.
Pageof 11